Hoʻohiki ka lāʻau lapaʻau hou i ka lāʻau lapaʻau no ka maʻi maʻi ʻaʻai

Ua wehewehe ka mana i loko o kahi ʻōlelo i ka Pōʻaono, ua kapa ʻia ka lāʻau lapaʻau hou ʻo "Balversa", a mālama ia i ka maʻi maʻi maʻi maʻi e laha ana ma muli o nā hoʻololi genetic i hoʻokumu ʻia e ka chemotherapy no ka maʻi kanesa.

Ua wehewehe nā mea noiʻi e pili ana nā maʻi maʻi maʻi ʻaʻai me nā hoʻololi genetic i loko o ka ʻōpū o ka mea maʻi a i ʻole ka urethra holoʻokoʻa, a ʻike ʻia kēia mau hoʻololi ʻana i hoʻokahi mea maʻi o kēlā me kēia 5 mau maʻi me ka maʻi maʻi ʻaʻai.

Ua ʻae ka mana i ka lāʻau lapaʻau hou ma hope o kahi hoʻokolohua lapaʻau i loaʻa i nā maʻi maʻi 87 me ka maʻi maʻi maʻi maʻi kiʻekiʻe, me nā genetic mutations.

ʻO ka helu o ka pane piha ʻana i ka lāʻau hou ma kahi o 32%, ʻoiai ʻo 30% o nā mea maʻi i loaʻa i kahi pane ʻāpana i ka lāʻau lapaʻau, a ʻo ka pane ʻana i ka mālama ʻana i mau no ka awelika o 5 a me ka hapa mahina.

Ua pane aku kekahi mau maʻi i ka lāʻau lapaʻau hou, ʻoiai ʻaʻole lākou i pane i ka wā ma mua i ka mālama ʻana me ka pembrolizumab, ʻo ia ka lāʻau maʻamau i hoʻohana ʻia i kēia manawa no nā poʻe maʻi me ka maʻi maʻi maʻi maʻi.

E pili ana i nā hopena ʻaoʻao maʻamau o ka lapaʻau ʻana, ua hōʻike ka mana he maʻi maʻi waha, manaʻo luhi, hoʻololi i ka hana o ke kīkī, ka maʻi maʻi, ka waha maloʻo, ka hoʻololi ʻana o ka hana ate, ka emi ʻana o ka makemake, nā maka maloʻo a me ka lauoho lauoho.

'O ka ma'i 'a'ai ma'i 'o ia kekahi o nā 'ano ma'i 'a'ai ma'amau, ma kahi o 76 mau hihia hou o ka ma'i 'a'ai ma'i ma'i i 'ike 'ia i kēlā me kēia makahiki, ma nā moku'āina 'ōlelo 'o US wale nō.

Ke ulu nei ka maʻi i loko o nā kāne ma kahi o 3 a 4 mau manawa ʻoi aʻe ma mua o nā wahine, a ʻo ka maʻi maʻi maʻi maʻi e ulu pinepine i ka poʻe ʻelemakule, a ʻo nā hōʻailona koʻikoʻi ʻo ia ke koko i loko o ka mimi, ka ʻeha i ka wā mimi, a me ka ʻeha pelvic.